BioSpace News Archive

IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced selected preliminary financial results for the fourth quarter that ended December 31, 2022.

Pasithea Therapeutics Corp. today announced its contract with WuXi STA, a subsidiary of WuXi AppTec, to manufacture the active pharmaceutical ingredient (“API”) for Pasithea’s macrocyclic, next-generation MEK Inhibitor, PAS-004 (formerly CIP-137401).

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the European Commission (EC) granted orphan drug designation for the company’s lead therapeutic candidate, efzofitimod, for the treatment of sarcoidosis based on the opinion of the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP).

Lunit (KRX:328130.KQ) today announced that it will deliver two poster presentations at the upcoming 2023 ASCO Gastrointestinal Cancers Symposium (ASCO GI), to be held in San Francisco, CA, and online from Jan. 19 – 21.

IceCure Medical Ltd today announced it has received a Notice of Allowance from the Japan Patent Office (the “JPO”) for IceCure’s patent application titled “Cryogen Pump”.

NeuroBo Pharmaceuticals, Inc. today announced that it has appointed Joseph Hooker as Interim Chief Executive Officer and President.

Freenome, a privately held biotech company, announced that Pennsylvania-based Geisinger is joining as a study partner for the Sanderson Study, a study for the detection of multiple cancers that pairs multiomics with real-world data.

The Lupus Research Alliance (LRA) is pleased to announce the appointment of Stacie J. Bell, PhD as Executive Vice President to lead Lupus Therapeutics, the organization’s clinical research affiliate.

Charles River Laboratories International, Inc. (NYSE: CRL) and Rznomics Inc. today announced a viral vector contract development and manufacturing organization (CDMO) partnership.

NiKang Therapeutics Inc. today announced that Dr. Anne Borgman has been appointed to the company’s Board of Directors.